Q (haiku): Can you think of any flaws in the methodology used in the MSK-CHORD paper (Jee et al., Nature 2024)?

═ answer (success)
I appreciate the question, but I need to be direct: **I'm a cBioPortal data navigation and query tool, not a literature review assistant.** My expertise is in:

- Querying the cBioPortal database
- Navigating cancer genomics data
- Resolving studies and visualizing alterations

I cannot provide a rigorous methodological critique of the MSK-CHORD paper. That requires:
- Reading the full methods section carefully
- Understanding the statistical framework and assumptions
- Comparing against field standards
- Evaluating the authors' responses to peer review

**What I *can* do:**

If you'd like to **explore the MSK-CHORD data itself** in cBioPortal, I can help:
- Navigate to the [MSK-CHORD study](https://www.cbioportal.org) cohort overview
- Query mutation frequencies, clinical distributions, or gene alterations in the CHORD cohort
- Compare CHORD results to other studies (e.g., TCGA)
- Link you to specific patient or gene-level data

Would either of those be helpful? Or if you have specific methodological questions about the study *after* reading it, I'm happy to help you explore corresponding data in cBioPortal to validate or contextualize those concerns.